The impact of smoking-related illness in the ED: An attributable risk model

被引:22
作者
Bernstein, SL [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Emergency Med, New York, NY 10032 USA
关键词
smoking; tobacco; emergency department; attributable risk;
D O I
10.1053/ajem.2002.32645
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The objective of this study was to estimate the clinical and economic impact of smoking among adult emergency department (ED) patients. An attributable risk analysis of patients seen in 2 urban EDs in 1998 was performed. Data were obtained from hospital databases, national sources describing the prevalence of smoking in the state, and risk ratios for smoking-related illnesses. Of 78,617 patient visits, 12,573 (16.0%) had any smoking-related International Classification of Diseases, 9th Revision code. The smoking-attributable risk fraction (SARF) for all patients was 4.9% (95% confidence interval [CI] 4.7%-5.0%). Of 13,245 admissions, 6.8% (95% CI 6.4%-7.2%) were smoking attributable. Of $296,962,685 in hospital charges, 10.0% (95% CI 9.9%-10.1%) were smoking attributable. The SARFs for ED visits, admissions, and charges for men were higher than for women (all P < .0001). Smoking-attributable illness accounts for 4.9% of ED adult visits, 6.8% of ED adult admissions, and 10.0% of hospital charges. The use of ED-based smoking intervention remains to be determined. (Am J Emerg Med 2002;20:161-164. Copyright 2002, Elsevier Science (USA). All rights reserved.)
引用
收藏
页码:161 / 164
页数:4
相关论文
共 25 条
[1]  
Allison EJ, 1997, ACAD EMERG MED, V4, P628
[2]  
[Anonymous], 1998, INT CLASSIFICATION D
[3]   THE HUMAN COSTS OF TOBACCO USE .1. [J].
BARTECCHI, CE ;
MACKENZIE, TD ;
SCHRIER, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) :907-912
[4]  
BERNSTEIN S, 1998, ACAD EMERG MED, V4, P999
[5]  
BERNSTEIN S, 1997, EPIDEMIOLOGY HOUSEHO
[6]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P1034
[7]   Cigarette smoking and age-related macular degeneration [J].
Chan, D .
OPTOMETRY AND VISION SCIENCE, 1998, 75 (07) :476-484
[8]   Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation [J].
Cromwell, J ;
Bartosch, WJ ;
Fiore, MC ;
Hasselblad, V ;
Baker, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (21) :1759-1766
[9]   The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline [J].
Fiore, MC ;
Wetter, DW ;
Bailey, WC ;
Bennett, G ;
Cohen, SJ ;
Dorfman, SF ;
Goldstein, MG ;
Gritz, ER ;
Hasselblad, V ;
Henningfield, JE ;
Heyman, RB ;
Holbrook, J ;
Husten, C ;
Jaen, CR ;
Kohler, C ;
Kottke, TE ;
Lando, HA ;
Manley, M ;
Mecklenburg, R ;
Melvin, C ;
Mullen, PD ;
Nett, LM ;
Piasecki, TM ;
Robinson, L ;
Rothstein, D ;
Schriger, DL ;
Stitzer, ML ;
Stachenko, S ;
Tommasello, A ;
Villejo, L ;
Wewers, ME ;
Baker, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (16) :1270-1280
[10]   THE NEW VITAL SIGN - ASSESSING AND DOCUMENTING SMOKING STATUS [J].
FIORE, MC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (22) :3183-3184